Hailir聽announced聽on聽September聽28,聽2020聽that聽the聽trial聽production聽plan聽of聽2,000聽tons聽prothioconazole聽fungicide聽technical,聽invested聽and聽constructed聽by聽its聽wholly-
owned聽subsidiary聽Shandong聽Hailir,聽met聽the聽trial聽production聽conditions聽after聽expert聽review聽and聽passed聽the聽review,聽and聽officially聽entered聽the聽trial聽production聽stage.
Prothioconazole聽has聽the聽good聽characteristics聽of聽disease聽prevention聽and聽treatment聽effects,聽obviously聽yield聽increase,聽and聽broad-spectrum聽bactericidal聽activity.聽It聽has聽a聽broad聽market聽prospect.聽The聽production聽of聽prothioconazole聽technical聽will聽bring聽new聽profit聽growth聽points聽to聽Hailir聽and聽become聽a聽new聽engine聽for聽its聽high-quality聽development,聽which聽will聽help聽further聽consolidate,聽enhance聽and聽optimize聽its聽core聽competitiveness,聽and聽have聽a聽positive聽impact聽on聽the聽continuous聽growth聽of聽the聽company's聽future聽performance.
It聽is聽understood聽that聽Hailir聽is聽actively聽planning聽to聽add聽the聽second聽projects聽for聽20,000聽tons聽of聽prothioconazole鈥檚聽key聽intermediate聽and聽5,000聽tons聽of聽prothioconazole聽technical聽production聽capacity.